Search research articles
Contact Us
Filters
Showing results (161-170 of 169) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 169 results.
The Lancet. Diabetes & Endocrinology
|
September 9, 2024
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials
Claire Vale, Peter J Godolphin, David Fisher, et al.
The Lancet. Haematology
|
June 29, 2023
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
Margaret V Ragni, Scott D Rothenberger, Robert Feldman, et al.
American Heart Journal
|
November 11, 2019
Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock
Marc Samsky, Mitchell Krucoff, Andrew D Althouse, et al.
JAMA Cardiology
|
October 9, 2024
Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial
Didier Tchétché, Roxana Mehran, Daniel J Blackman, et al.
Circulation
|
June 25, 2023
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial
Scott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, et al.
American Heart Journal
|
October 4, 2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock
Marc D Samsky, Mitchell W Krucoff, David A Morrow, et al.
The New England Journal of Medicine
|
April 8, 2024
Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus
Howard C Herrmann, Roxana Mehran, Daniel J Blackman, et al.
The Lancet. Diabetes & Endocrinology
|
September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
Mikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
JAMA Network Open
|
May 25, 2023
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial
Jeffrey S Berger, Matthew D Neal, Lucy Z Kornblith, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 169) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 169 results.
The Lancet. Diabetes & Endocrinology
|
September 9, 2024
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials
Claire Vale, Peter J Godolphin, David Fisher, et al.
The Lancet. Haematology
|
June 29, 2023
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
Margaret V Ragni, Scott D Rothenberger, Robert Feldman, et al.
American Heart Journal
|
November 11, 2019
Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock
Marc Samsky, Mitchell Krucoff, Andrew D Althouse, et al.
JAMA Cardiology
|
October 9, 2024
Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial
Didier Tchétché, Roxana Mehran, Daniel J Blackman, et al.
Circulation
|
June 25, 2023
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial
Scott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, et al.
American Heart Journal
|
October 4, 2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock
Marc D Samsky, Mitchell W Krucoff, David A Morrow, et al.
The New England Journal of Medicine
|
April 8, 2024
Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus
Howard C Herrmann, Roxana Mehran, Daniel J Blackman, et al.
The Lancet. Diabetes & Endocrinology
|
September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
Mikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
JAMA Network Open
|
May 25, 2023
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial
Jeffrey S Berger, Matthew D Neal, Lucy Z Kornblith, et al.
Page
of 17